scholarly article | Q13442814 |
P50 | author | Keith A Jolley | Q41049408 |
Noel D McCarthy | Q51690524 | ||
Dominique A Caugant | Q57906958 | ||
P2093 | author name string | Martin C J Maiden | |
Jenny Kremastinou | |||
Martin Musilek | |||
Daniel J Wilson | |||
Siamak P Yazdankhah | |||
Paula Kriz | |||
Georgina Tzanakaki | |||
Jitka Kalmusova | |||
Torill Alvestad | |||
P2860 | cites work | The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) | Q24530652 |
Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data | Q24532809 | ||
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms | Q24685491 | ||
DnaSP, DNA polymorphism analyses by the coalescent and other methods | Q27860965 | ||
The genetical structure of populations | Q29616058 | ||
Population genetics and molecular epidemiology of Neisseria meningitidis. | Q30431048 | ||
Mechanisms of neisserial serum resistance | Q33670874 | ||
The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum | Q33769638 | ||
Electrophoretic variation in adenylate kinase of Neisseria meningitidis is due to inter- and intraspecies recombination | Q33782317 | ||
The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis | Q33879680 | ||
Epidemiology and pathogenesis of Neisseria meningitidis | Q33960403 | ||
Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak | Q33964109 | ||
Carried meningococci in the Czech Republic: a diverse recombining population | Q33970597 | ||
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story | Q34093820 | ||
Meningococcal disease | Q34239234 | ||
Multi-locus sequence typing: a tool for global epidemiology | Q34269596 | ||
Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease | Q34439721 | ||
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease | Q35615516 | ||
Capsule switching of Neisseria meningitidis | Q35910306 | ||
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern | Q36239022 | ||
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica | Q36472571 | ||
Global epidemiology of meningococcal disease | Q36634411 | ||
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China | Q36972946 | ||
Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers | Q36998242 | ||
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. | Q37071251 | ||
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada | Q37244869 | ||
Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. | Q39600992 | ||
Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. | Q39841939 | ||
Meningococcal Disease: Still with Us | Q40145726 | ||
Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. | Q41063588 | ||
Immunological Investigations of Meningococcal Disease: III. Brevity of Group C Acquisition Prior to Disease Occurrence | Q41303877 | ||
Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis | Q42726217 | ||
Many carried meningococci lack the genes required for capsule synthesis and transport | Q43450474 | ||
Recent emergence of serogroup C meningococcal disease in Greece | Q44456305 | ||
Intercontinental spread of an epidemic group A Neisseria meningitidis strain | Q44510020 | ||
The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis | Q45038075 | ||
Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? | Q46218788 | ||
Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis | Q47854732 | ||
Sequence type analysis and recombinational tests (START). | Q48327962 | ||
Manson Lecture. Meningococcal meningitis in Africa | Q48580950 | ||
Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. | Q50657172 | ||
The carrier state: Neisseria meningitidis. | Q50698369 | ||
Carriage ofNeisseria meningitidisandNeisseria lactamicain northern Greece | Q53915046 | ||
Meningococcal conjugate vaccines: new opportunities and new challenges | Q57707307 | ||
Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec | Q58856133 | ||
The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996 | Q59230866 | ||
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex | Q64128132 | ||
Neisseria meningitidis Carriage during an Outbreak of Serogroup C Disease | Q64134088 | ||
Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA | Q67276564 | ||
Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986 | Q68355973 | ||
Non-usefulness of meningococcal carriage-rates | Q69998849 | ||
Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA | Q70395802 | ||
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease | Q71538870 | ||
Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37 | Q71749007 | ||
Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model | Q72682674 | ||
Genetic Basis for NongroupableNeisseria meningitidis | Q73332286 | ||
Rapid serogroup switching in Neisseria meningitidis | Q73394674 | ||
Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37 | Q74148260 | ||
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease | Q74382398 | ||
Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine | Q75306184 | ||
Dynamics of the meningococcal carrier state and characteristics of the carrier strains: a longitudinal study within three cohorts of military recruits | Q77331597 | ||
Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods | Q77579882 | ||
Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic | Q77904409 | ||
Uncloaking the meningococcus: dynamics of carriage and disease | Q78165406 | ||
Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain | Q78805114 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Norway | Q20 |
Greece | Q41 | ||
Czech Republic | Q213 | ||
Neisseria meningitidis | Q154625 | ||
P304 | page(s) | 5146-5153 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway | |
P478 | volume | 42 |
Q37669807 | A common gene pool for the Neisseria FetA antigen. |
Q34746633 | An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands |
Q38775024 | An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence |
Q92156626 | Atypical, Yet Not Infrequent, Infections with Neisseria Species |
Q34570146 | Automated extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar. |
Q37727051 | Biofilm formation by the human pathogen Neisseria meningitidis |
Q52352963 | Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design. |
Q38011316 | Can we, should we, eradicate the meningococcus? |
Q59244167 | Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine |
Q58667869 | Carriage and transmission of Neisseria meningitidis |
Q37929754 | Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region |
Q33696949 | Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease |
Q35188450 | Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation |
Q37944323 | Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century |
Q43490036 | Characteristics of Neisseria meningitidis isolates causing fatal disease |
Q35760344 | Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia) |
Q39140508 | Characterization of Neisseria meningitidis isolates from Egypt using multilocus sequence typing |
Q33770335 | Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015. |
Q35708801 | Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets |
Q37021368 | Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: Epidemiological links to returning travellers |
Q36363154 | Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. |
Q33704817 | Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba |
Q33280136 | Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana |
Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
Q89930481 | Complete genome and methylome analysis of Neisseria meningitidis associated with increased serogroup Y disease |
Q43234686 | Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease |
Q36098684 | Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms |
Q43083529 | Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia |
Q35191042 | Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells |
Q33438433 | Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis |
Q45121011 | Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa |
Q43624944 | Distribution of serogroups and sequence types in disease-associated and carrier strains of Neisseria meningitidis isolated in China between 2003 and 2008. |
Q34513606 | Distribution of the type III DNA methyltransferases modA, modB and modD among Neisseria meningitidis genotypes: implications for gene regulation and virulence. |
Q33600936 | Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine |
Q42363077 | Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt |
Q33594778 | Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen |
Q37316748 | Epidemiological evidence for the role of the hemoglobin receptor, hmbR, in meningococcal virulence. |
Q36382175 | Evolutionary and genomic insights into meningococcal biology |
Q36600323 | Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135. |
Q37309237 | Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement |
Q35623008 | Extensive genomic variation within clonal complexes of Neisseria meningitidis. |
Q64891926 | Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab. |
Q33686914 | Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field. |
Q37387763 | Genealogical typing of Neisseria meningitidis. |
Q35913820 | Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada |
Q34231871 | Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis |
Q40126952 | Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms |
Q30374765 | Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5. |
Q38991142 | Genomic analysis of urogenital and rectal Neisseria meningitidis isolates reveals encapsulated hyperinvasive meningococci and coincident multidrug-resistant gonococci |
Q42614141 | Genomic basis of a polyagglutinating isolate of Neisseria meningitidis |
Q35689140 | Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland |
Q37333542 | Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002. |
Q57531180 | Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity |
Q38875043 | Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil. |
Q55303290 | Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature. |
Q33743483 | Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development |
Q51742865 | Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents. |
Q33752108 | Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. |
Q33521231 | Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008) |
Q37333471 | Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules |
Q40245353 | Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections. |
Q91738418 | Insights on Population Structure and Within-Host Genetic Changes among Meningococcal Carriage Isolates from U.S. Universities |
Q55246888 | Interplay Between Virulence and Variability Factors as a Potential Driver of Invasive Meningococcal Disease. |
Q35942903 | Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003. |
Q41584736 | Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals |
Q35586928 | Late repression of NF-κB activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells |
Q36711465 | Lessons from meningococcal carriage studies |
Q51724279 | Long-term evolution of antigen repertoires among carried meningococci. |
Q90636882 | Loss of Genomic Diversity in a Neisseria meningitidis Clone Through a Colonization Bottleneck |
Q36154043 | Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines |
Q28246008 | Meningococcal carriage and disease--population biology and evolution |
Q42260617 | Meningococcal carriage during a clonal meningococcal B outbreak in France |
Q33274203 | Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. |
Q34068118 | Metabolism and virulence in Neisseria meningitidis |
Q33703560 | Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. |
Q37473667 | Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. |
Q42088370 | Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil. |
Q34776133 | Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011 |
Q33913048 | Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines |
Q34231743 | Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters |
Q34568989 | Multiple-locus variable-number tandem repeat analysis of Neisseria meningitidis yields groupings similar to those obtained by multilocus sequence typing |
Q35687415 | Neisseria Base: a comparative genomics database for Neisseria meningitidis |
Q41995737 | Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A Unique Pediatric Case |
Q38550405 | Neisseria meningitidis infection: who, when and where? |
Q34632986 | Neisseria meningitidis: biology, microbiology, and epidemiology. |
Q91199458 | Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis |
Q38481856 | Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis |
Q38325374 | Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives |
Q36671962 | Patterns of antigenic diversity and the mechanisms that maintain them |
Q34064278 | Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4. |
Q34428829 | Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database |
Q40895395 | Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013. |
Q81193637 | Phenotypic assessment of Neisseria meningitidis isolates obtained from patients with invasive meningococcal disease in Greece, 1993-2003: implications for serogroup B vaccines based on PorA serosubtype antigens |
Q37281265 | Population genomics: diversity and virulence in the Neisseria |
Q37478257 | Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease |
Q34499619 | Prevalence and clinical course in invasive infections with meningococcal endotoxin variants |
Q37461347 | Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy |
Q92860306 | Rare Case of Community-Acquired Endocarditis Caused by Neisseria meningitidis Assessed by Clinical Metagenomics |
Q37417745 | Risk of transmitting meningococcal infection by transient contact on aircraft and other transport. |
Q34836342 | Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis |
Q36825737 | Routinely vaccinating adolescents against meningococcus: targeting transmission & disease |
Q28554935 | Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015 |
Q40268126 | Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies |
Q34075291 | Structural alterations in a component of cytochrome c oxidase and molecular evolution of pathogenic Neisseria in humans |
Q42834603 | Structure-function relationships of the competence lipoprotein ComL and SSB in meningococcal transformation. |
Q35912710 | Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis |
Q37464760 | Targeting of immune signalling networks by bacterial pathogens |
Q36064003 | Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia. |
Q34500581 | The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains |
Q91784819 | The comparative population genetics of Neisseria meningitidis and Neisseria gonorrhoeae |
Q33610843 | The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology |
Q42577186 | The endgame for serogroup a meningococcal disease in Africa? |
Q37706585 | The epidemiology of meningococcal disease and the impact of vaccines |
Q44533068 | The polysialic acid-specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases |
Q38989580 | The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey. |
Q33466005 | Tracing the evolution of competence in Haemophilus influenzae |
Q64078188 | Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens |
Q41932534 | Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease |
Q35877401 | Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany |
Q34042132 | Variable-number tandem repeat analysis of meningococcal isolates belonging to the sequence type 162 complex |
Q38350786 | Variation of the factor H-binding protein of Neisseria meningitidis |
Q33889347 | Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome |
Q57181124 | WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene |
Q36491155 | Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis |